Using two genetically distinct paediatric glioblastoma cell lines, SF188 and KNS42, in vitro1H-NMR analysis following treatment with the dual pan-Class I PI3K/mTOR inhibitor PI-103 resulted in a decrease in lactate and phosphocholine (PC) levels (P<0.02) relative to control. This evidence concerns the gene MTOR and glioblastoma.